OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials
Xinxin Deng, Liying Zhou, Cui Liang, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Xinxin Deng, Liying Zhou, Cui Liang, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
The preclinical discovery and development of atogepant for migraine prophylaxis
Carlo Baraldi, Dagmar Beier, Paolo Martelletti, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 783-788
Open Access | Times Cited: 9
Carlo Baraldi, Dagmar Beier, Paolo Martelletti, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 783-788
Open Access | Times Cited: 9
The efficacy and safety of zavegepant nasal inhalation versus oral calcitonin-gene related peptide receptor antagonists in the acute treatment of migraine: a systematic review and network meta-analysis of the literature
Zixiang Zhu, Yanbing Tang, Long‐Yuan Li, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Zixiang Zhu, Yanbing Tang, Long‐Yuan Li, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics
Deirdre M. Boucherie, Rúben Dammers, Arnaud Vincent, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Deirdre M. Boucherie, Rúben Dammers, Arnaud Vincent, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment
Lanfranco Pellesi, Budour Jedie, Fadia Barhum, et al.
Pain Management (2025), pp. 1-6
Closed Access
Lanfranco Pellesi, Budour Jedie, Fadia Barhum, et al.
Pain Management (2025), pp. 1-6
Closed Access
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists
Marta Waliszewska‐Prosół, Bianca Raffaelli, Marcin Straburzyński, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1039-1051
Closed Access | Times Cited: 2
Marta Waliszewska‐Prosół, Bianca Raffaelli, Marcin Straburzyński, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1039-1051
Closed Access | Times Cited: 2
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence
Lars Edvinsson
Expert Review of Neurotherapeutics (2024), pp. 1-15
Open Access
Lars Edvinsson
Expert Review of Neurotherapeutics (2024), pp. 1-15
Open Access
Evaluating Modern Therapeutic Interventions for Migraine Management: A Systematic Review
Lovett S Achiatar, Iqra Nasir, Zainab Zia, et al.
Cureus (2024)
Open Access
Lovett S Achiatar, Iqra Nasir, Zainab Zia, et al.
Cureus (2024)
Open Access
